Search result for: Psoriasis Biosimilars

June 2026

Psoriasis Biosimilars Market Size, Share and Trends 2026 to 2035

  • Report Code : 5163
  • Published : June 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global psoriasis biosimilars market size is evaluated at USD 10.46 billion in 2025 and is projected to attain around USD 29.78 billion by 2035, with a CAGR of 11.03%.

July 2026

Biosimilars Market Size, Share and Trends 2026 to 2035

  • Report Code : 1359
  • Published : July 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global biosimilars market size is exhibited at USD 40.36 billion in 2025 and is projected to hit around USD 191.29 billion by 2035, growing at a solid CAGR of 16.84%.

June 2026

Immunology Biosimilars Market Size, Share and Trends 2026 to 2035

  • Report Code : 5935
  • Published : June 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global immunology biosimilars market size was estimated at USD 11.23 billion in 2025 and is expected to hit around USD 56.39 billion by 2035, growing at a CAGR of 17.51%.

March 2026

Psoriasis Treatment Market Size, Share and Trends 2026 to 2035

  • Report Code : 2034
  • Published : March 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global psoriasis treatment market size is expected to increase from USD 34.14 billion in 2025 and is projected to hit around USD 73.04 billion by 2035, with a CAGR of 7.9%.

March 2026

Biologics and Biosimilars Market Size, Share and Trends 2026 to 2035

  • Report Code : 8097
  • Published : March 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global biologics and biosimilars market size is estimated to hit around USD 2,426.85 billion by 2035 increasing from USD 610.41 billion in 2025, with a CAGR of 14.80%.